source
- STAT invites reader debate on blue zones and open-access publishing feesTorie Bosch, editor of STAT’s First Opinion platform, has published an opinion piece encouraging readers to submit letters responding to recent essays. The article explains that STAT will publish…
- Daraxonrasib doubles median survival in pancreatic cancer trial, FDA grants early accessAn international study presented at the American Society of Clinical Oncology meeting in Chicago showed that patients with pancreatic cancer who received daraxonrasib lived an average of 13.2 month…